Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/21/2003CA2513198A1 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003CA2492097A1 Signal for packaging of influenza virus vectors
08/21/2003CA2491547A1 Methods and composition for modulating type i muscle formation using pgc-1.alpha.-
08/21/2003CA2482333A1 Human antibodies for therapy against vaccinia or smallpox
08/21/2003CA2476561A1 Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same
08/21/2003CA2476556A1 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003CA2476530A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003CA2476468A1 Protein carrier system for therapeutic oligonucleotides
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476232A1 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003CA2476165A1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
08/21/2003CA2475929A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003CA2475926A1 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
08/21/2003CA2475838A1 Cytotoxic t-cell epitopes from chlamydia
08/21/2003CA2475802A1 Methods and compositions for use in spliceosome mediated rna trans-splicing
08/21/2003CA2475768A1 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
08/21/2003CA2475696A1 Novel method for production of dna biochips and applications thereof
08/21/2003CA2475605A1 Deoxyribozymes
08/21/2003CA2475388A1 Chimeric molecules for cleavage in a treated host
08/21/2003CA2475373A1 Oligonucleotide analogues and methods of use for modulating gene expression
08/21/2003CA2475177A1 Materials and methods for preparing dimeric growth factors
08/21/2003CA2475102A1 Stabilized synthetic immunogen delivery systems
08/21/2003CA2474890A1 Method of diagnosis of inflammatory diseases using calgranulin c
08/21/2003CA2474885A1 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003CA2474844A1 Cks1 inhibitors
08/21/2003CA2474782A1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
08/21/2003CA2474364A1 Functionalization of carotenoid compounds
08/21/2003CA2474082A1 Process for producing starch hydrolysate
08/21/2003CA2473816A1 Gene function inferring using gene expression data
08/21/2003CA2471392A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003CA2452897A1 Cardiotoxin molecular toxicology modeling
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336662A2 Dna chip, sample analysis apparatus and method thereof
08/20/2003EP1336658A1 G1/S phase specific, S phase specific and meristem specific transcription control element in a transcribed region
08/20/2003EP1336657A1 Process for producing coenzyme q 10?
08/20/2003EP1336656A2 20 human secreted proteins
08/20/2003EP1336655A1 Method of identifying protein CAMS (constitutively active mutants)
08/20/2003EP1336652A1 Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells
08/20/2003EP1336620A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
08/20/2003EP1336618A1 Porcine complement regulator factor H and its use
08/20/2003EP1336617A2 Conotoxins having acetylcholin receptor binding properties
08/20/2003EP1336433A1 Multi-well microfiltration apparatus
08/20/2003EP1336109A1 Kit and method for detecting the esm-1 protein
08/20/2003EP1336088A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium
08/20/2003EP1335991A2 Method for detecting protozoae of the genus naegleria
08/20/2003EP1335989A1 Method for generating recombinant polynucleotides
08/20/2003EP1335987A2 Modified vaccinia ankara virus variant
08/20/2003EP1335986A2 Phosphatase stress-related proteins and methods of use in plants
08/20/2003EP1335985A2 Process for increasing the level of sterols in plants
08/20/2003EP1335984A1 Determination of hydrophobic coenzyme a esters and other lipids using a biosensor comprising a modified coenzyme a- and acyl-coa binding protein (acbp)
08/20/2003EP1335983A2 55054, a human metalloprotease and uses therefor
08/20/2003EP1335982A2 Secondary liquefaction of starch in ethanol production
08/20/2003EP1335981A2 13237, 18480, 2245 or 16228 human protein kinase molecules and uses therefor
08/20/2003EP1335980A2 Nucleotide sequences coding for the cysq gene
08/20/2003EP1335979A2 Herbicide target genes and methods
08/20/2003EP1335978A2 Regulation of human extracellular calcium-sensing g protein-coupled receptor
08/20/2003EP1335977A2 Human v2 vomeronasal receptor
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335975A2 "47324", a human g-protein and uses therefor
08/20/2003EP1335973A2 Regulation of human adenylate cyclase
08/20/2003EP1335953A2 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
08/20/2003EP1335938A2 Apolipoprotein analogues
08/20/2003EP1335935A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
08/20/2003EP1335934A1 Gene encoding protein cluster i and the encoded protein
08/20/2003EP1335933A2 Pna analogues
08/20/2003EP1335932A1 Isolation of lectins
08/20/2003EP1335926A2 Method of separating extra-chromosomal dna from other cellular components
08/20/2003EP1335744A2 Sdf-1 beta expressing tumor cells as tumor vaccines
08/20/2003EP1335741A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
08/20/2003EP1335646A2 Transgenic or recombinant non-human mammals and their uses in screening psycho-active medicines
08/20/2003EP1335645A2 Inhibition of gene expression using polynucleotide analogues
08/20/2003EP1259599A4 Cell fusion assays using fluorescence resonance energy transfer
08/20/2003EP1239836B1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
08/20/2003EP1147213A4 Novel rgs-containing molecules and uses thereof
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1093381B1 Antigenic peptides derived from telomerase
08/20/2003EP1047711B1 Nucleic acid sequences encoding capsaicin receptors
08/20/2003EP0868511B1 Utrophin gene expression
08/20/2003EP0856059B1 Methods for production of recombinant plasmids
08/20/2003EP0843684B1 Universal solid supports and methods for their use
08/20/2003EP0837935B1 3' utr of the human prohibitin gene
08/20/2003EP0830606B1 Assessing calcineurin's role in immunosuppression and neurotoxicity
08/20/2003EP0817852B1 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
08/20/2003EP0804615B1 Apolipoprotein e polymorphism and treatment of alzheimer's disease
08/20/2003EP0754240B1 Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis
08/20/2003EP0721510B1 Anti-cancer gene therapy by modulation of immune or inflammatory response
08/20/2003EP0672067B1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
08/20/2003EP0324789B1 Methods of regulating metabolic stability of proteins
08/20/2003CN1437656A Method for stable chromosomal multi-copy integration of genes
08/20/2003CN1437655A Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
08/20/2003CN1437654A Antigenic proteins of shrimp white spot syndrome virus uses thereof
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1437613A Modified morbillivirus V proteins
08/20/2003CN1437612A Nucleotide sequence of influenza A/Udorn/72(H3N2) genome
08/20/2003CN1437477A A Memory enhancing protein
08/20/2003CN1437476A Optimized minigenes and peptides encoded thereby
08/20/2003CN1437443A Hypersensitive response (HR)-elicitor to inhibit post harvest disease or desiccation of fruits or vegetables
08/20/2003CN1436857A Specificity determination and application of one section of candida albicans DNA sequence
08/20/2003CN1436854A Production process of human horny cell growth factor-2
1 ... 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 ... 4023